PHLPP1 and acute myeloid leukemia: The presence of either phosphatase does not cause statistically significant difference in OS or in EFS, but we found the highest expression level of PHLPP provided significantly worse OS (median 1 vs. 10 months, p = 0.033) among full cohort of AML patients.